The NNCC Learning Collaborative will review national rates of opioid use disorder and hepatitis C virus. Presenters will review different HCV testing and treatment models from various health settings and locations. Content experts will also discuss how programs have started to integrate substance use disorder treatment, specific to the opioid crisis. Participants in the virtual learning collaborative will attend four (4) learning sessions consisting of live web-based platform training and facilitated office hours on Tuesdays throughout October through early December of 2019 and will take place via the Zoom video conferencing platform.
1. To discuss NASTAD's current landscape of opioid and infectious disease and resources available for health settings to improve screening, testing, and treatment options for patients.
2. To review NNCC's AmeriCorps State Program that will expand opioid outreach and awareness to decrease stigma and provide education about medication-assisted therapy and other resources in Philadelphia, PA.